GlassScriptPhysician profile
David V Daniels
NPI 1629121975
$318,681.34
in general payments reported to CMS, 2019-2025
21 companies · $25K in 2025
The $25K reported for 2025 was more than what 94% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83K · 2020: $47K · 2021: $78K · 2022: $50K · 2023: $714 · 2024: $34K · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $33K · Consulting Fee: $18K · Food and Beverage: $4,144 · Travel and Lodging: $3,453 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $33,212.55 |
| Consulting Fee | $18,325.00 |
| Food and Beverage | $4,144.19 |
| Travel and Lodging | $3,453.48 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $475.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $191,727.85 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Evoque |
| Teleflex LLC | $59,285.95 | 2019-2025 | Arrow, Manta |
| Jenavalve Technology, INC. | $21,730.61 | 2019-2021 | |
| Vascular Solutions, INC. | $15,152.50 | 2019-2020 | |
| Abbott Laboratories | $14,758.49 | 2019-2022 | |
| Medtronic, INC. | $12,349.64 | 2021-2025 | Corevalve Evolut R, Symplicity G3 |
| Medtronic Vascular, INC. | $1,503.67 | 2019-2020 | |
| Boston Scientific Corporation | $719.90 | 2019-2024 | |
| Abiomed | $276.36 | 2019-2022 | |
| Shockwave Medical, INC | $237.81 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $194.97 | 2021-2025 | (9266) Elca, (Br1) Coronary Specialty Balloon, Coronary Other |
| Acist Medical Systems, INC. | $185.21 | 2019-2023 | |
| Biotronik INC. | $158.34 | 2019 | |
| Cardiovascular Systems INC. | $99.67 | 2019 | |
| Seigla Medical, INC. | $86.43 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $53.13 | 2019-2022 | |
| Teleflex Medical Canada INC. | $48.32 | 2020 | |
| Angiodynamics, INC. | $45.49 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.65 | 2019-2025 | Lifevest |
| Merit Medical Systems INC | $23.35 | 2023 | |
| Arrow International, INC. | $18.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Daniels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.